Diamyd Medical AB (publ)
DYMDF
$0.73
$0.000.00%
OTC PK
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 7.80K | 2.40K | 1.80K | 4.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 7.80K | 2.40K | 1.80K | 4.90K |
| Cost of Revenue | 96.80K | 98.40K | 103.10K | 78.90K | 88.60K |
| Gross Profit | -96.80K | -90.60K | -100.70K | -77.10K | -83.80K |
| SG&A Expenses | 1.51M | 1.18M | 1.39M | 1.03M | 1.09M |
| Depreciation & Amortization | 168.70K | 143.00K | 144.50K | 654.70K | 136.30K |
| Other Operating Expenses | -108.40K | -94.50K | -37.10K | -103.80K | -23.90K |
| Total Operating Expenses | 4.89M | 4.18M | 4.08M | 4.94M | 3.86M |
| Operating Income | -4.89M | -4.17M | -4.08M | -4.94M | -3.85M |
| Income Before Tax | -4.46M | -4.09M | -3.44M | -4.73M | -3.76M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.46M | -4.09M | -3.44M | -4.73M | -3.76M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.46M | -4.09M | -3.44M | -4.73M | -3.76M |
| EBIT | -4.89M | -4.17M | -4.08M | -4.94M | -3.85M |
| EBITDA | -4.72M | -4.01M | -3.93M | -4.80M | -3.71M |
| EPS Basic | -0.04 | -0.04 | -0.03 | -0.05 | -0.04 |
| Normalized Basic EPS | -0.03 | -0.02 | -0.03 | -0.02 | -0.02 |
| EPS Diluted | -0.04 | -0.04 | -0.03 | -0.05 | -0.04 |
| Normalized Diluted EPS | -0.03 | -0.02 | -0.03 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 105.90M | 104.09M | 102.31M | 99.72M | 96.61M |
| Average Diluted Shares Outstanding | 105.90M | 104.09M | 102.31M | 99.72M | 96.61M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |